Trial Profile
A Single-dose, Randomized, Two-period, Two-treatment, Two-sequence, Crossover Bioequivalence Study on a Olostar Tab Versus Two Co-administered Reference Products Olmesartan Medoxomil and Rosuvastatin Calcium in Healthy Volunteers
Status:
Recruiting
Phase of Trial:
Phase I
Latest Information Update: 05 Sep 2017
Price :
$35
*
At a glance
- Drugs Olmesartan medoxomil/rosuvastatin (Primary) ; Olmesartan medoxomil; Rosuvastatin
- Indications Hyperlipidaemia; Hypertension
- Focus Pharmacokinetics
- Sponsors Daewoong Pharmaceutical
- 01 Oct 2015 New trial record